Alpha-1 Antitrypsin Therapy Modifies Neutrophil Adhesion in Patients with Obstructive Lung Disease

Area of Science:

• Biochemistry
• Cell Biology
• Immunology

Background:

• Alpha-1 antitrypsin deficiency (AATD) is linked to neutrophil-driven inflammation and emphysema.
• Neutrophil plasma membrane cholesterol is crucial for adhesion and tissue transmigration.

Purpose of the Study:

• Investigate mechanisms of heightened neutrophil adhesion in AATD.
• Determine if alpha-1 antitrypsin (AAT) augmentation therapy can reverse these adhesion-related changes.

Main Methods:

• Analyzed neutrophil membrane proteins via liquid chromatography-tandem mass spectrometry.
• Assessed effects of AAT augmentation therapy using calcium fluorometric, μ-calpain, and cell adhesion assays.
• Compared neutrophils from healthy controls, AATD patients, and AATD patients post-therapy.

Main Results:

• AATD neutrophils showed decreased membrane cholesterol, increased integrins (α-M, α-L), and talin-1.
• Elevated cytosolic calcium in AATD neutrophils activated μ-calpain, degrading caveolin-1.
• AAT therapy restored caveolin-1 and cholesterol levels, decreasing integrin expression and neutrophil adhesion.

Conclusions:

• AATD involves neutrophil membrane alterations driven by calcium-dependent μ-calpain activity.
• AAT augmentation therapy offers an auxiliary benefit by reducing circulating inflammation and controlling neutrophil adhesion.
• Restoration of neutrophil membrane integrity and function is a key outcome of AAT therapy in AATD.